Medical Care Technologies Inc.
MDCE · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| FCF Yield | 0.00% | 1.20% | 1.24% | -0.30% |
| EV / EBITDA | -283.07 | 54.76 | 39.77 | -445.56 |
| Quality | ||||
| ROIC | -0.49% | 7.52% | 7.60% | -1.92% |
| Gross Margin | 61.86% | 45.92% | 56.79% | 5.30% |
| Cash Conversion Ratio | -1.64 | -0.51 | 0.52 | 0.50 |
| Growth | ||||
| Revenue 3-Year CAGR | -32.72% | -35.05% | -41.37% | -42.59% |
| Free Cash Flow Growth | 0.00% | 49.22% | 264.41% | 95.78% |
| Safety | ||||
| Net Debt / EBITDA | 2.68 | 0.14 | -0.07 | -1.90 |
| Interest Coverage | -3.64 | 0.00 | 89.82 | -9.71 |
| Efficiency | ||||
| Inventory Turnover | 0.02 | 0.16 | 0.00 | 0.00 |
| Cash Conversion Cycle | 4,165.94 | 562.73 | 0.00 | 0.00 |